Clinical Trials Logo

Clinical Trial Summary

This is a Single arm, Single centre trial to check the safety and efficacy of bone marrow derived autologous mono nuclear cell(100 millions per dose )clinical trial to be conducted for 36 months in patients with optic nerve diseases.


Clinical Trial Description

Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibres may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent papillary defect. primary out put of clinical study is to measures Improvement in visual loss and improvement in idiopathic intra cranial.This is a Single arm, Single centre trial to check the safety and efficacy of bone marrow derived autologous mono nuclear cell(100 millions per dose )clinical trial to be conducted for 36 months . ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01834079
Study type Interventional
Source Chaitanya Hospital, Pune
Contact Sachin P Jamadar, D.Ortho
Phone +918888788880
Email sac2751982@gmail.com
Status Recruiting
Phase Phase 1/Phase 2
Start date September 2014
Completion date July 2016

See also
  Status Clinical Trial Phase
Completed NCT04680143 - Systemic Erythropoietin Injection in Patients Having Optic Atrophy Phase 1/Phase 2
Completed NCT04594590 - Natural History Study of SLC25A46 Mutation-related Mitochondriopathy
Completed NCT04580979 - Natural History Study of FDXR Mutation-related Mitochondriopathy
Recruiting NCT03011541 - Stem Cell Ophthalmology Treatment Study II N/A
Completed NCT01064505 - Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients Phase 1
Recruiting NCT05147701 - Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases Phase 1
Not yet recruiting NCT02882477 - Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy Phase 2/Phase 3
Completed NCT04723160 - Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph